Paul Smith

Person

Wilmington, DE, US

People

Patents Grantslast 30 patents

Information Patent Grant
JAK1 pathway inhibitors for the treatment of gastrointestinal disease
- Patent number 12,150,943
- Issue date Nov 26, 2024
- Incyte Corporation
- Krishnaswamy Yeleswaram
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
JAK inhibitor with a vitamin D analog for treatment of skin diseases
- Patent number 12,005,067
- Issue date Jun 11, 2024
- Incyte Corporation
- Paul Smith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of JAK1 inhibitors for the treatment of cutaneous lupus erythem...
- Patent number 11,992,490
- Issue date May 28, 2024
- Incyte Corporation
- Paul Smith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
JAK1 pathway inhibitors for the treatment of vitiligo
- Patent number 11,957,661
- Issue date Apr 16, 2024
- Incyte Corporation
- Paul Smith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Combination therapy comprising JAK pathway inhibitor and rock inhib...
- Patent number 11,918,581
- Issue date Mar 5, 2024
- Incyte Corporation
- Michael Peel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
JAK1 pathway inhibitors for the treatment of gastrointestinal disease
- Patent number 11,596,632
- Issue date Mar 7, 2023
- Incyte Corporation
- Krishnaswamy Yeleswaram
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treatment of hidradenitis suppurativa using JAK inhibitors
- Patent number 11,304,949
- Issue date Apr 19, 2022
- Incyte Corporation
- Michael D. Howell
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
JAK INHIBITOR WITH A VITAMIN D ANALOG FOR TREATMENT OF SKIN DISEASES
- Publication number 20250049817
- Publication date Feb 13, 2025
- INCYTE CORPORATION
- Paul SMITH
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
RUXOLITINIB FOR THE TREATMENT OF PRURIGO NODULARIS
- Publication number 20250032498
- Publication date Jan 30, 2025
- INCYTE CORPORATION
- Paul SMITH
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION THERAPY COMPRISING JAK PATHWAY INHIBITOR AND ROCK INHIB...
- Publication number 20240293411
- Publication date Sep 5, 2024
- INCYTE CORPORATION
- Michael Peel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
RUXOLITINIB FOR THE TREATMENT OF PRURIGO NODULARIS
- Publication number 20240075040
- Publication date Mar 7, 2024
- INCYTE CORPORATION
- Paul SMITH
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
RUXOLITINIB FOR THE TREATMENT OF PRURIGO NODULARIS
- Publication number 20240024328
- Publication date Jan 25, 2024
- INCYTE CORPORATION
- Paul Smith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Topical formulations of PI3K-delta inhibitors
- Publication number 20230190755
- Publication date Jun 22, 2023
- INCYTE CORPORATION
- Indushekhar Persaud
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
JAK1 PATHWAY INHIBITORS FOR THE TREATMENT OF GASTROINTESTINAL DISEASE
- Publication number 20230172939
- Publication date Jun 8, 2023
- INCYTE CORPORATION
- Krishnaswamy Yeleswaram
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
JAK1 PATHWAY INHIBITORS FOR THE TREATMENT OF PRURIGO NODULARIS
- Publication number 20220378746
- Publication date Dec 1, 2022
- INCYTE CORPORATION
- Paul Smith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
RUXOLITINIB FOR THE TREATMENT OF PRURIGO NODULARIS
- Publication number 20220347179
- Publication date Nov 3, 2022
- INCYTE CORPORATION
- Paul Smith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF HIDRADENITIS SUPPURATIVA USING JAK INHIBITORS
- Publication number 20220241286
- Publication date Aug 4, 2022
- INCYTE CORPORATION
- Michael D. Howell
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION THERAPY COMPRISING JAK PATHWAY INHIBITOR AND ROCK INHIB...
- Publication number 20220226327
- Publication date Jul 21, 2022
- INCYTE CORPORATION
- Michael Peel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
JAK INHIBITOR WITH A VITAMIN D ANALOG FOR TREATMENT OF SKIN DISEASES
- Publication number 20220202834
- Publication date Jun 30, 2022
- INCYTE CORPORATION
- Paul SMITH
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
JAK1 PATHWAY INHIBITORS FOR THE TREATMENT OF VITILIGO
- Publication number 20220175731
- Publication date Jun 9, 2022
- INCYTE CORPORATION
- Paul Smith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF JAK1 INHIBITORS FOR THE TREATMENT OF CUTANEOUS LUPUS ERYTHEM...
- Publication number 20210113566
- Publication date Apr 22, 2021
- INCYTE CORPORATION
- Paul Smith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
JAK1 PATHWAY INHIBITORS FOR THE TREATMENT OF GASTROINTESTINAL DISEASE
- Publication number 20200197399
- Publication date Jun 25, 2020
- INCYTE CORPORATION
- Krishnaswamy Yeleswaram
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF HIDRADENITIS SUPPURATIVA USING JAK INHIBITORS
- Publication number 20190328739
- Publication date Oct 31, 2019
- INCYTE CORPORATION
- Michael D. Howell
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Person

Patents Grantslast 30 patents

JAK1 pathway inhibitors for the treatment of gastrointestinal disease

JAK inhibitor with a vitamin D analog for treatment of skin diseases

Use of JAK1 inhibitors for the treatment of cutaneous lupus erythem...

JAK1 pathway inhibitors for the treatment of vitiligo

Combination therapy comprising JAK pathway inhibitor and rock inhib...

JAK1 pathway inhibitors for the treatment of gastrointestinal disease

Treatment of hidradenitis suppurativa using JAK inhibitors

Patents Applicationslast 30 patents

JAK INHIBITOR WITH A VITAMIN D ANALOG FOR TREATMENT OF SKIN DISEASES

RUXOLITINIB FOR THE TREATMENT OF PRURIGO NODULARIS

COMBINATION THERAPY COMPRISING JAK PATHWAY INHIBITOR AND ROCK INHIB...

RUXOLITINIB FOR THE TREATMENT OF PRURIGO NODULARIS

RUXOLITINIB FOR THE TREATMENT OF PRURIGO NODULARIS

Topical formulations of PI3K-delta inhibitors

JAK1 PATHWAY INHIBITORS FOR THE TREATMENT OF GASTROINTESTINAL DISEASE

JAK1 PATHWAY INHIBITORS FOR THE TREATMENT OF PRURIGO NODULARIS

RUXOLITINIB FOR THE TREATMENT OF PRURIGO NODULARIS

TREATMENT OF HIDRADENITIS SUPPURATIVA USING JAK INHIBITORS

COMBINATION THERAPY COMPRISING JAK PATHWAY INHIBITOR AND ROCK INHIB...

JAK INHIBITOR WITH A VITAMIN D ANALOG FOR TREATMENT OF SKIN DISEASES

JAK1 PATHWAY INHIBITORS FOR THE TREATMENT OF VITILIGO

USE OF JAK1 INHIBITORS FOR THE TREATMENT OF CUTANEOUS LUPUS ERYTHEM...

JAK1 PATHWAY INHIBITORS FOR THE TREATMENT OF GASTROINTESTINAL DISEASE

TREATMENT OF HIDRADENITIS SUPPURATIVA USING JAK INHIBITORS